Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Components of the cell death machine and drug sensitivity of the National Cancer Institute Cell Line Panel.

Svingen PA, Loegering D, Rodriquez J, Meng XW, Mesner PW Jr, Holbeck S, Monks A, Krajewski S, Scudiero DA, Sausville EA, Reed JC, Lazebnik YA, Kaufmann SH.

Clin Cancer Res. 2004 Oct 15;10(20):6807-20.

2.

The major apoptotic pathway activated and suppressed by poliovirus.

Belov GA, Romanova LI, Tolskaya EA, Kolesnikova MS, Lazebnik YA, Agol VI.

J Virol. 2003 Jan;77(1):45-56.

3.

Inactivation of the apoptosis effector Apaf-1 in malignant melanoma.

Soengas MS, Capodieci P, Polsky D, Mora J, Esteller M, Opitz-Araya X, McCombie R, Herman JG, Gerald WL, Lazebnik YA, Cordón-Cardó C, Lowe SW.

Nature. 2001 Jan 11;409(6817):207-11.

PMID:
11196646
4.

Evaluation of Apaf-1 and procaspases-2, -3, -7, -8, and -9 as potential prognostic markers in acute leukemia.

Svingen PA, Karp JE, Krajewski S, Mesner PW Jr, Gore SD, Burke PJ, Reed JC, Lazebnik YA, Kaufmann SH.

Blood. 2000 Dec 1;96(12):3922-31.

5.

Primary cells suppress oncogene-dependent apoptosis.

Duelli DM, Lazebnik YA.

Nat Cell Biol. 2000 Nov;2(11):859-62.

PMID:
11056544
6.

Caspase-3-dependent cleavage of Bcl-2 promotes release of cytochrome c.

Kirsch DG, Doseff A, Chau BN, Lim DS, de Souza-Pinto NC, Hansford R, Kastan MB, Lazebnik YA, Hardwick JM.

J Biol Chem. 1999 Jul 23;274(30):21155-61.

7.

Oncogene-dependent apoptosis is mediated by caspase-9.

Fearnhead HO, Rodriguez J, Govek EE, Guo W, Kobayashi R, Hannon G, Lazebnik YA.

Proc Natl Acad Sci U S A. 1998 Nov 10;95(23):13664-9.

8.

Oncogene-dependent apoptosis in extracts from drug-resistant cells.

Fearnhead HO, McCurrach ME, O'Neill J, Zhang K, Lowe SW, Lazebnik YA.

Genes Dev. 1997 May 15;11(10):1266-76.

9.

Cleavage of lamin A by Mch2 alpha but not CPP32: multiple interleukin 1 beta-converting enzyme-related proteases with distinct substrate recognition properties are active in apoptosis.

Takahashi A, Alnemri ES, Lazebnik YA, Fernandes-Alnemri T, Litwack G, Moir RD, Goldman RD, Poirier GG, Kaufmann SH, Earnshaw WC.

Proc Natl Acad Sci U S A. 1996 Aug 6;93(16):8395-400.

10.

Studies of the lamin proteinase reveal multiple parallel biochemical pathways during apoptotic execution.

Lazebnik YA, Takahashi A, Moir RD, Goldman RD, Poirier GG, Kaufmann SH, Earnshaw WC.

Proc Natl Acad Sci U S A. 1995 Sep 26;92(20):9042-6.

11.

Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis.

Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle M, Lazebnik YA, et al.

Nature. 1995 Jul 6;376(6535):37-43.

PMID:
7596430
12.

Characterization of the execution phase of apoptosis in vitro using extracts from condemned-phase cells.

Lazebnik YA, Takahashi A, Poirier GG, Kaufmann SH, Earnshaw WC.

J Cell Sci Suppl. 1995;19:41-9.

PMID:
8655646
13.

Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE.

Lazebnik YA, Kaufmann SH, Desnoyers S, Poirier GG, Earnshaw WC.

Nature. 1994 Sep 22;371(6495):346-7.

PMID:
8090205
14.
15.

Drop-delay measurement using enzyme-coated particles.

Lazebnik YA, Poletaev AI, Zenin VV.

Cytometry. 1992;13(6):649-52.

16.

Reversible G2 block in the cell cycle of Ehrlich ascites carcinoma cells.

Lazebnik YA, Medvedeva ND, Zenin VV.

Exp Cell Res. 1991 Jul;195(1):247-54.

PMID:
2055271

Supplemental Content

Loading ...
Support Center